1996
DOI: 10.1007/bf02500385
|View full text |Cite
|
Sign up to set email alerts
|

Caclaneal bua changes in a 2 year placebo controlled study of pamidronate in post menopausal osteoporosis

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
3
0

Year Published

1997
1997
2000
2000

Publication Types

Select...
4
1

Relationship

0
5

Authors

Journals

citations
Cited by 6 publications
(3 citation statements)
references
References 0 publications
0
3
0
Order By: Relevance
“…To date few studies have reported drug effects [48,[78][79][80][81] or addressed the usefulness of ultrasound to monitor treatment of osteoporosis. Mainly four studies with two year follow-up measurements have studied the changes in QUS parameters between controls and women treated with calcitonin [48], hormone replacement therapy [81] and bisphosphonates [79,80].…”
Section: Conclusion Drawn From Current In Vivo Studies?mentioning
confidence: 99%
See 1 more Smart Citation
“…To date few studies have reported drug effects [48,[78][79][80][81] or addressed the usefulness of ultrasound to monitor treatment of osteoporosis. Mainly four studies with two year follow-up measurements have studied the changes in QUS parameters between controls and women treated with calcitonin [48], hormone replacement therapy [81] and bisphosphonates [79,80].…”
Section: Conclusion Drawn From Current In Vivo Studies?mentioning
confidence: 99%
“…Mainly four studies with two year follow-up measurements have studied the changes in QUS parameters between controls and women treated with calcitonin [48], hormone replacement therapy [81] and bisphosphonates [79,80]. These changes were statistically significant for treatment with calcitonin and HRT but not with the bisphosphonate.…”
Section: Conclusion Drawn From Current In Vivo Studies?mentioning
confidence: 99%
“…The absence of ionising radiation, the portability of the equipment and its cost-effectiveness make this method an attractive option for managing osteoporosis; thus, it may be used eventually to follow patients after therapeutic interventions for osteoporosis [40,41,42,43,44].…”
Section: Discussionmentioning
confidence: 99%